Dynamic effects of door-to-balloon time delay on revascularization efficacy and myocardial enzyme levels in patients with acute anterior myocardial infarction

TENG Chao, ZHANG Jieliang, MO Jiechao, XU Junguo

Journal of Hunan Normal University(Medical Science) ›› 2025, Vol. 22 ›› Issue (4) : 54-59.

PDF(1838 KB)
PDF(1838 KB)
Journal of Hunan Normal University(Medical Science) ›› 2025, Vol. 22 ›› Issue (4) : 54-59.
Clinical Medicine

Dynamic effects of door-to-balloon time delay on revascularization efficacy and myocardial enzyme levels in patients with acute anterior myocardial infarction

  • TENG Chao, ZHANG Jieliang, MO Jiechao, XU Junguo
Author information +
History +

Abstract

Objective To investigate the impact of door-to-balloon (D2B) time delay on revascularization efficacy and the dynamic changes of myocardial enzyme levels in patients with acute anterior myocardial infarction (AMI). Methods A retrospective analysis was conducted on 105 patients diagnosed with acute anterior wall myocardial infarction (AMI) who were admitted to our hospital and underwent percutaneous coronary intervention (PCI) between July 1, 2022, and June 30, 2024. Patients were evenly assigned to three groups (n=35 per group) based on the time from first medical contact to balloon inflation (door-to-balloon time, D2B): Group A (D2B ≤60 minutes), Group B (60 minutes <D2B≤120 minutes), and Group C (D2B>120 minutes). Post-treatment comparisons among the groups included clinical efficacy, success rate of coronary revascularization, time to symptom relief, and length of hospital stay. Serial measurements of myocardial enzyme levels—creatine kinase (CK) and creatine kinase isoenzyme-MB (CK-MB) —were performed at 6, 12, 24, and 72 hours after PCI to evaluate dynamic changes in myocardial injury. In addition, cardiac function was assessed using left ventricular ejection fraction (LVEF), left ventricular end-systolic volume (LVESV), and left ventricular end-diastolic volume (LVEDV). The incidence of adverse cardiac events was also recorded and compared across the three groups. Results Group A demonstrated a significantly higher overall efficacy rate (94.29%) compared to Group B (77.14%) and Group C (71.43%). The success rate of revascularization in Group A (97.14%) was also significantly greater than in Groups B (82.86%) and C (77.14%). Time to symptom relief and hospital stay were notably shorter in Group A. Baseline CK and CK-MB levels showed no significant differences among the groups; however, at 6, 12, 24, and 72 hours post-treatment, levels in Group A were significantly lower than in the other groups. All groups showed improvement in LVEF after treatment, with the greatest increase observed in Group A. Additionally, reductions in LVEDV and LVESV were most pronounced in Group A. The incidence of adverse events in Group A was 2.86%, compared with 8.57% in Group B and 22.86% in Group C. The differences between groups were not statistically significant. Conclusion Shorter D2B time is associated with better clinical outcomes in patients with acute anterior AMI undergoing PCI. Prompt intervention significantly enhances revascularization success.

Key words

acute anterior myocardial infarction / door-to-balloon time / percutaneous coronary intervention / myocardial enzyme markers / cardiac function

Cite this article

Download Citations
TENG Chao, ZHANG Jieliang, MO Jiechao, XU Junguo. Dynamic effects of door-to-balloon time delay on revascularization efficacy and myocardial enzyme levels in patients with acute anterior myocardial infarction[J]. Journal of Hunan Normal University(Medical Science). 2025, 22(4): 54-59

References

[1] 王会丽, 张文琪, 桑海燕. 新型炎症标志物预测急性心肌梗死后左心室血栓的研究进展[J]. 中国实验诊断学, 2024, 28(10): 1247-1250.
[2] LIN G, CHEN W, WU M, et al.The Value of Sacubitril/Valsartan in Acute Anterior Wall ST-Segment Elevation Myocardial Infarction before Emergency Percutaneous Coronary Intervention[J]. Cardiology, 2022, 147(5-6): 479-485.
[3] HASSAN MO, AHMED SA, HASSAN MS, et al.Door-to-Balloon Time and Mortality Among Patients Undergoing Primary PCI, Challenges and Experience from Somalia's Largest PCI Center[J]. Int J Gen Med, 2024, 22(17): 237-244.
[4] YAMAMOTO K, SHIOMI H, MORIMOTO T, et al.Target Lesion Revascularization After Intravascular Ultrasound-Guided Percutaneous Coronary Intervention[J]. Circ Cardiovasc Interv, 2023, 16(5): 1292-1295.
[5] HUSSAIN M, KUMAR R, AMMAR A, et al.Frequency of Thrombolysis in Myocardial Infarction III Flow in Patients With Primary Percutaneous Coronary Intervention: Not All Culprit Vessels Are Completely Occluded in ST Elevation Myocardial Infarction[J]. Cureus, 2020, 12(12): 1203-1206.
[6] 葛均波, 徐永健. 内科学[M]. 第8版. 北京: 人民卫生出版社, 2013.
[7] 中华医学会心血管病学分会介入心脏病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 中华心血管病杂志编辑委员会. 中国经皮冠状动脉介入治疗指南 (2016)[J]. 中华心血管病杂志, 2016, 44(5): 382-400.
[8] 中国医师协会急诊医师分会, 国家卫健委能力建设与继续教育中心急诊学专家委员会, 中国医疗保健国际交流促进会急诊急救分会. 急性冠脉综合征急诊快速诊治指南 (2019)[J]. 中国急救医学, 2019, 39(4): 421-428.
[9] VVICHOVA T, MALY M, ULMAN J, et al.Mortality in patients with TIMI 3 flow after PCI in relation to time delay to reperfusion[J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 2016, 160(1): 118-124.
[10] 张艳慧. 急性ST段抬高型心肌梗死患者门-球时间延迟现状及影响因素[J]. 上海护理, 2023, 23(12): 36-39.
[11] 叶旭东, 彭瑜, 张钲. aVR导联T波直立与急性心肌梗死患者PCI后发生主要不良心血管事件的关系研究[J]. 实用心脑肺血管病杂志, 2023, 31(5): 25-29.
[12] KURMI P, TRIPATHI VD, TRIPATHI SK.Impact of total ischemic time on clinical outcomes in patients with ST-elevation myocardial infarction: lost time is never found again[J]. Cureus, 2022, 14(3): 2314-2317.
[13] WANG J, MENG Y, HAN S, et al.Predictive value of total ischaemic time and T1 mapping after emergency percutaneous coronary intervention in acute ST-segment elevation myocardial infarction[J]. Clin Radiol, 2023, 78(10): 724-731.
[14] 李世震. 急性前壁心肌梗死患者在不同时间窗接受急诊冠状动脉介入治疗的效果[J]. 中西医结合心血管病电子杂志, 2023, 11(29): 26-28.
[15] SAITO R, KOYAMA K, KONGOJI K, et al.Acute myocardial infarction with simultaneous total occlusion of the left anterior descending artery and right coronary artery successfully treated with percutaneous coronary intervention[J]. BMC Cardiovasc Disord, 2022, 22(1): 206-209.
[16] 邢靖贤, 袁永刚, 耿涛. 不同时间窗冠状动脉介入治疗对急性心肌梗死患者心功能及脑卒中发生情况的影响[J]. 临床心血管病杂志, 2021, 37(8): 710-714.
[17] 李建光, 李莉, 翟晓娟, 等. 提前肝素化对ST段抬高型心肌梗死患者冠状动脉血流的影响及时间依赖性[J]. 心脏杂志, 2023, 35(5): 535-539.
[18] RADWAN HI, ALHOSEENY AMA, GHONIEM SM, et al.Early right ventricular dysfunction after primary percutaneous coronary intervention in anterior versus isolated inferior myocardial infarction assessed by tissue Doppler imaging and speckle tracking echocardiography[J]. Heart Fail Rev, 2023, 28(2): 407-417.
[19] BUTT TS, BASHTAWI E, BOUOUN B, et al.Door-to-balloon time in the treatment of ST segment elevation myocardial infarction in a tertiary care center in Saudi Arabia[J]. Ann Saudi Med, 2020, 40(4): 281-289.
[20] 孙璐, 许长存, 侯玉萍. 急性前壁心肌梗死患者静脉溶栓后不同时间行经皮冠状动脉介入治疗的对比研究[J]. 中国循证心血管医学杂志, 2021, 13(2): 231-235.
[21] 赵久平, 孟令东, 李俊. STEMI患者冠脉造影特征与PCI后无复流的关系及相关风险因素预测模型建立初探[J]. 湖南师范大学学报 (医学版), 2021, 18(5): 180-183.
[22] 张涛, 李爱敏, 张金霞, 等. 急性ST段抬高型心肌梗死总缺血时间与急诊经皮冠状动脉介入治疗后1年内主要不良心血管事件发生风险的关系[J]. 中国循环杂志, 2024, 39(10): 976-982.
PDF(1838 KB)

Accesses

Citation

Detail

Sections
Recommended

/